Kawasaki disease in a pediatric intensive care unit: A case-control study

Pediatrics

Volumn 122, Issue 4, 2008, Pages

  Dominguez, Samuel R ^a,b   Friedman, Kevin ^a   Seewald, Ryan ^b   Anderson, Marsha S ^a,b   Willis, Lisa ^a,b   Glode, Mary P ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

ICU; Kawasaki disease; Shock

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; IMMUNOGLOBULIN; INFLIXIMAB; STEROID;

ALBUMIN BLOOD LEVEL; ARTICLE; CASE CONTROL STUDY; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; HOSPITAL ADMISSION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; REPEATED DRUG DOSE; SCHOOL CHILD; SEPTIC SHOCK; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; THERAPY DELAY; THROMBOCYTE COUNT; COMPARATIVE STUDY; DIAGNOSTIC ERROR; HOSPITALIZATION; INFANT; INTENSIVE CARE; RETROSPECTIVE STUDY;

CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC ERRORS; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS, PEDIATRIC; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATIENT ADMISSION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 54049114272     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1275     Document Type: Article

References (18)

1. Burns JC, Glode MP. Kawasaki syndrome. Lancet. 2004; 364(9433):533-544
2. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association [published correction appears in Pediatrics. 2005; 115(4):1118]. Pediatrics. 2004;114(6):1708-1733
3. Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics. 2001;107(3). Available at: www.pediatrics.org/cgi/content/ full/107/3/e33
4. Yanagawa H, Nakamura Y, Yashiro M, et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. Pediatrics. 1998;102(6). Available at: www.pediatrics.org/cgi/content/ full/102/6/e65
5. Anderson MS, Todd JK, Glode MP. Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics. 2005; 115(4). Available at: www.pediatrics.org/cgi/content/full/115/ 4/e428
6. Rosenfeld EA, Corydon KE, Shulman ST. Kawasaki disease in infants less than one year of age. J Pediatr. 1995;126(4): 524-529
7. Chang FY, Hwang B, Chen SJ, Lee PC, Meng CC, Lu JH. Characteristics of Kawasaki disease in infants younger than six months of age. Pediatr Infect Dis J. 2006;25(3):241-244
8. Minich LL, Sleeper LA, Atz AM, et al. Delayed diagnosis of Kawasaki disease: what are the risk factors? Pediatrics. 2007; 120(6). Available at: www.pediatrics.org/cgi/content/full/120/ 6/e1434
9. Davies HD, Kirk V, Jadavji T, Kotzin BL. Simultaneous presentation of Kawasaki disease and toxic shock syndrome in an adolescent male. Pediatr Infect Dis J. 1996;15(12):1136-1138
10. Gamillscheg A, Zobel G, Karpf EF, et al. Atypical presentation of Kawasaki disease in an infant. Pediatr Cardiol. 1993;14(4): 223-226
11. Chan L, Chinnock B. Clinicopathological conference: multisystem failure in a child. Acad Emerg Med. 2000;7(2):169-173
12. Egami K, Muta H, Ishii M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr. 2006;149(2):237-240
13. Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki
14. disease. Circulation. 2006;113(22):2606-2612
15. Sano T, Kurotobi S, Matsuzaki K, et al. Prediction of non- responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment. Eur J Pediatr. 2007;166(2):131-137
16. Uehara R, Belay ED, Maddox RA, et al. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J. 2008;27(2):155-160
17. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclas- sified as normal in Kawasaki disease. J Pediatr. 1998;133(2): 254-258
18. Kurotobi S, Nagai T, Kawakami N, Sano T. Coronary diameter in normal infants, children and patients with Kawasaki disease. Pediatr Int. 2002;44(1):1-4